Abdominal compression device to limit breathing motion during lung cancer radiotherapy
Tests whether a compression device reduces breathing movement in adults with lung cancer.
Key facts
- Who runs it
- Tianjin Medical University Cancer Institute and Hospital
- Where
- Tianjin, ChinaSee the site
- Trial code
- Registry title
- Feasibility and Effectiveness of Respiratory Movement Management in Lung Cancer Receiving Stereotactic Radiotherapy Using a Novel Positional Fixation Device
- Status
- Recruiting
- People taking part
- 50 people, planned
- Started
- 10 May 2026
- Expected to end
- 31 Dec 2026
- Type of study
- Observational, 2 groups
- Treatments tested
- Chest and abdominal compression
- breathing management
- Record updated
- 1 May 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with a single lung cancer tumor at the edge of the lung who can have stereotactic body radiotherapy (SBRT). It tests a belly pressure device that limits breathing movement.
- Age
- 18 years or older
- Sex
- All sexes can join
- Disease stage
- One solitary peripheral lung cancer, judged by the doctors to be treatable with SBRT
Main reasons for not taking part
- Central or super central lung cancer in people who cannot or do not want to have breathing suppression and chest and abdominal compression fixation
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- Clinical diagnosis is solitary peripheral lung cancer, and after comprehensive evaluation by the participating physicians based on the patient's clinical data, it is suitable for receiving SBRT treatment
Who cannot take part
- Central or super central lung cancer patients who are intolerant or unwilling to undergo respiratory suppression and chest and abdominal compression fixation
Where in China
- Tianjin Medical University Cancer Institute and HospitalTianjin, ChinaContact: Xu Yao YuTaking people
About the trial
What the trial wants to find out
The purpose of this clinical trial is to understand the safety and effectiveness of abdominal pressure devices in inhibiting respiratory movement in lung cancer patients. The main question it aims to answer is:
Read full original descriptionShow less
Did the abdominal pressure device reduce the respiratory movement of participants with lung cancer tumors?
Participants will:
Record how much they use abdominal pressure devices to suppress lung cancer tumor respiratory movement
The 2 groups in the trial
- Breathing management group
CT/4DCT scan under breathing management
Treatment: Chest and abdominal compression and breathing management
- No breathing management group
CT/4DCT scan under free breathing
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- A Single Center, Translational Study on the Feasibility and Effectiveness of Respiratory Movement Management in Lung Cancer Patients Receiving Stereotactic Radiotherapy Using a Novel Positional Fixation Device
- Plain-language title
- Abdominal compression device to limit breathing motion during lung cancer radiotherapyGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 13 November 2026.
- Record updated
- 1 May 2026